JSIS - Cassa Malattia
If you have undergone problems with specific reimbursements
(medical treatments now negatively affected by the new coefficients are marked
red at
this link) you can now lodge your own complaint by using the document at
this link.
We take the opportunity to thank all our colleagues who
filled in our JSIS Survey.
We are happy to give all staff our support with this
important topic.
Furthermore, R&D is now pleased
to offer our members a dedicated Help-Desk concerning problems encountered with
the service offered by them: please feel free to pass by the
Secretariat or to make an appointment with our R&D colleagues if you wish
to avail of this service. We’ll do our best to help you and try to find a
solution, and your privacy will be safeguarded at all times.
Nuovo distaccamento di vigili del fuoco
Read the full article
R&D Cafè and survey on JSIS (Cassa Malattia)
If you have undergone any kind of problem (late reimbursement,
refusals, prior authorisations, extremely penalising application of the new
parity coefficients, etc) or if you are happy with the service provided, please fill in the short anonymous survey form at this address.
The deadline to respond is 9/4.
During the R&D Café on 10th
April at 13 (Amphitheatre – bdg.36) we will present a summary of all
responses and a discussion of the conclusions. We will also provide you with
details concerning an Article 90 complaint
we have recently submitted against the new parity coefficients (which affect
the payment thresholds for medical expenses reimbursements – see Complaint No. R/231/13) for the JSIS
introduced on 1st January 2013. A template for
use by all staff for further Article 90 complaints against specific expense
claim settlements will also be presented, which we hope will be
useful when specific problems are encountered during this year.
Further to the general information we are collecting in the
survey, we are of course happy to give you our support with any specific issues
you may have: please feel free to pass by at the Secretariat or to make an
appointment with our R&D colleagues if you wish. Your privacy will be
safeguarded at all times.
Subscribe to:
Posts
(
Atom
)
No comments :
Post a Comment